Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07565246 · ClinicalTrials.gov registry record
A Study to Understand the Analgesic Properties of Topically Applied Menthol When Used in a Marathon.
A clinical trial, sponsored by Reckitt Benckiser Healthcare (UK) Limited.
- Completed
- Registry status
- 367
- Enrollment target
NCT07565246 is a clinical trial that has completed, run by Reckitt Benckiser Healthcare (UK) Limited. The registered enrollment target is 367 participants.
The verdict
NCT07565246 has completed, sponsored by Reckitt Benckiser Healthcare (UK) Limited.
- COMPLETED
- Registry status
- 367 participants
- Enrollment target
Study Summary
The purpose of the research study is to gather the opinions and/or perceptions relating to the use of topically applied menthol and experience of pain during and after a marathon in adult runners (18+ years) participating in the 2025 Chicago Marathon. The main questions it aims to answer are: * Does topically applied menthol reduce pain levels in marathon runners during recovery? * How quickly does pain relief occur after topically applied menthol application? * What are the sensory attributes (e.g., cooling sensation) associated with topically applied menthol use during and after the race? * How do demographic factors (e.g., age, sex, menstrual cycle stage, sleep quality) influence pain experience and topically applied menthol effectiveness? Researchers will compare pre- and post-application pain scores in the Recovery Application Zone to see if Biofreeze provides measurable pain relief and sensory benefits. Participants will: * Provide documented informed consent prior to participation. * Self-select to use Biofreeze products during or after the race. * Complete one or both of the following: 1. Recovery Application Zone Questionnaire (includes pain score before and after Biofreeze application, sensory assessments, demographics). 2. End of Race Questionnaire (includes retrospective recall of pain relief, product use, sensory experience, and demographic data).
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 367 participants |
| Start Date | 2025-10-12 |
| Est. Completion | 2025-10-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07565246
The ClinicalTrials.gov registry entry for NCT07565246 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 367 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reckitt Benckiser Healthcare (UK) Limited, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT07565246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07565246 about?
NCT07565246 is a clinical study titled "A Study to Understand the Analgesic Properties of Topically Applied Menthol When Used in a Marathon.". The purpose of the research study is to gather the opinions and/or perceptions relating to the use of topically applied menthol and experience of pain during and after a marathon in adult runners (18+ years) participating in the 2025 Chicago Marathon. The main questions it aims to answer are: * Doe...
What is the current status of trial NCT07565246?
This trial is currently completed. The enrollment target is 367 participants. The study started on 2025-10-12. Estimated completion is 2025-10-12.
What interventions are being tested in trial NCT07565246?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT07565246?
This trial is sponsored by Reckitt Benckiser Healthcare (UK) Limited, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.